INTRODUCTION: Rosette-forming glioneuronal tumour of the fourth ventricle is a rarely described entity. While usually having an indolent course and hence classified as a WHO grade 1 tumour, the precise characteristics and risk of recurrence of this tumour are still unknown. In addition, the preferred treatment modality remains unclear. DISCUSSION: We present a case of an 8-year old with an early recurrence of 9 months after undergoing a sub-total resection of her tumour. Following further resection, there was no tumour present on the 3-month follow-up. In order to better characterise this tumour entity, we performed a review of the available literature on the subject. We found that it mainly affected young adults and had a female predominance. While initially these tumours were described in the fourth ventricle, the current literature suggests that they may be found in a larger variety of sites within the brain and spinal cord. There are several reports of recurrence occurring between 9 months and 10 years following surgery. There is as yet no feature of the tumour that appears to predict the risk of recurrence. CONCLUSION: This phenomenon warrants further examination to discover if there is a sub-section of tumours that is likely to recur, and until this is established, all patients should be followed up at regular intervals.
INTRODUCTION: Rosette-forming glioneuronal tumour of the fourth ventricle is a rarely described entity. While usually having an indolent course and hence classified as a WHO grade 1 tumour, the precise characteristics and risk of recurrence of this tumour are still unknown. In addition, the preferred treatment modality remains unclear. DISCUSSION: We present a case of an 8-year old with an early recurrence of 9 months after undergoing a sub-total resection of her tumour. Following further resection, there was no tumour present on the 3-month follow-up. In order to better characterise this tumour entity, we performed a review of the available literature on the subject. We found that it mainly affected young adults and had a female predominance. While initially these tumours were described in the fourth ventricle, the current literature suggests that they may be found in a larger variety of sites within the brain and spinal cord. There are several reports of recurrence occurring between 9 months and 10 years following surgery. There is as yet no feature of the tumour that appears to predict the risk of recurrence. CONCLUSION: This phenomenon warrants further examination to discover if there is a sub-section of tumours that is likely to recur, and until this is established, all patients should be followed up at regular intervals.
Authors: Istvan Vajtai; Marlène Arnold; Andreas Kappeler; Olivia Jeless; Anton Lukes; Luigi Mariani; Werner Paulus Journal: Pathol Res Pract Date: 2007-07-24 Impact factor: 3.250
Authors: Vivek Joseph; Adam Wells; Yu-Hung Kuo; Steve Halcrow; Brian Brophy; Grace Scott; J Manavis; Jeff Swift; Peter C Blumbergs Journal: Neuropathology Date: 2008-07-18 Impact factor: 1.906
Authors: Lucas Tadeu Bidinotto; Cristovam Scapulatempo-Neto; Alan Mackay; Gisele Caravina de Almeida; Bernd Walter Scheithauer; Gustavo Noriz Berardinelli; Raul Torrieri; Carlos Afonso Clara; Leonir Terezinha Feltrin; Marta Viana-Pereira; Marileila Varella-Garcia; Chris Jones; Rui Manuel Reis Journal: PLoS One Date: 2015-09-15 Impact factor: 3.240
Authors: Caleb P Wilson; Arpan R Chakraborty; Panayiotis E Pelargos; Helen H Shi; Camille K Milton; Sarah Sung; Tressie McCoy; Jo Elle Peterson; Chad A Glenn Journal: Neurooncol Adv Date: 2020-09-09